Barclays raised the firm’s price target on UiPath to $15 from $14 and keeps an Equal Weight rating on the shares. The company’s “solid” Q2 results are a first step to rebuild credibility for management, the analyst tells investors in a research note. The firm says that despite concerns about disruption from the recent CEO change and headcount reduction, UiPath delivered slightly better than expected results. Investors likely need to see a few quarters like this, but the shares will come off their lows, contends Barclays.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH: